Company Overview

Generex Pharmaceuticals Inc., is an emerging Pharmaceutical and Bio-technology company to serve global markets from its base in Toronto. The company is committed to providing high quality pharmaceuticals and to make a significant improvement in patient care.

BIO-TECHNOLOGY represents our major business area. Generex has developed and patented 3 novel drug delivery systems technologies designed to administer proteins and peptides orally. Currently these products can only be administered by injection. The first application is insulin, where we are proving at the present time that our orally administered insulin formulation provides results similar to those achieved by injection. The benefits of Generex's oral insulin to diabetics are enormous, both from a therapy stand point and from a quality of life (no more needles) perspective.

Generex is also exploring other applications for its proprietary technologies. As a result it will test and prove the appropriate applications, and will then identify local licensees to market them on our behalf. We may also look for different technologies and products to evaluate and acquire for North American markets and/or globally.

BIO-TECHNOLOGY Generex has developed and patented 3 novel drug delivery systems technologies designed to administer proteins and peptides orally. Currently these products can only be administered by injection. The first application is insulin, where we are proving at the present time that our orally administered insulin formulation provides results similar to those achieved by injection. The benefits of Generex's oral insulin to diabetics are enormous, both from a therapy stand point and from a quality of life (no more needles) perspective.

Company Information

Additional Details

Legal Name: Generex Biotechnology Corp.

Number of Employees: 23

Total Sales ($CDN): $100,000 - $200,000

Contacts

Products

• Bio-technology

NAICS Categories

• 325410 Pharmaceutical and Medicine Manufacturing

Additional Information